» Articles » PMID: 39444612

Fentanyl Enhances Immune Cell Response Through TLR4/MD-2 Complex

Overview
Journal Front Pharmacol
Date 2024 Oct 24
PMID 39444612
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Opioids have been shown to induce neuroinflammation and immune cell activation, that might contribute to some of the opioid side effects, such as opioid-induced tolerance and paradoxical hyperalgesia. In this context, TLR4/MD-2 complex has been proposed as an off-target site for opioid action. This study was aimed at investigating the effect of fentanyl on lipopolysaccharide (LPS)-induced TLR4/MD-2 activation in rat primary microglia and human monocyte-derived macrophages (MDM).

Materials And Methods: The effect of fentanyl was first explored by measuring the expression and release of different proinflammatory mediators in primary rat microglia and human MDM by real-time PCR and ELISA. Then, the involvement of TLR4/MD-2 signaling was investigated studying NF-κB activation in HEK293 cells stably transfected with human TLR4, MD-2, and CD14 genes (HEK-Blue hTLR4 cells) and in human MDM.

Results: Fentanyl increased mRNA levels, as well as the LPS-induced secretion of proinflammatory mediators in primary microglia and MDM. Two inhibitors of TLR4/MD-2 signaling, namely the oxazoline derivative of -palmitoylethanolamine (PEA-OXA) and CLI-095, blocked the production and release of proinflammatory cytokines by microglia stimulated with LPS and fentanyl, suggesting that TLR4/MD-2 could be the target of the proinflammatory activity of fentanyl. Finally, we showed that fentanyl in combination with LPS activated NF-κB signaling in human MDM and in HEK-Blue hTLR4 cells and this effect was blocked by inhibitors of TLR4/MD-2 complex.

Discussion: These results provide new insight into the mechanism of the proinflammatory activity of fentanyl, which involves the activation of TLR4/MD-2 signaling. Our findings might facilitate the development of novel inhibitors of TLR4/MD-2 signaling to combine with opioid-based analgesics for effective and safe pain management.

References
1.
Eidson L, Murphy A . Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine. J Neurosci. 2013; 33(40):15952-63. PMC: 3787504. DOI: 10.1523/JNEUROSCI.1609-13.2013. View

2.
Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S . Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010; 330(6005):841-5. PMC: 3719181. DOI: 10.1126/science.1194637. View

3.
Tedesco S, De Majo F, Kim J, Trenti A, Trevisi L, Fadini G . Convenience versus Biological Significance: Are PMA-Differentiated THP-1 Cells a Reliable Substitute for Blood-Derived Macrophages When Studying Polarization?. Front Pharmacol. 2018; 9:71. PMC: 5826964. DOI: 10.3389/fphar.2018.00071. View

4.
Hutchinson M, Shavit Y, Grace P, Rice K, Maier S, Watkins L . Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol Rev. 2011; 63(3):772-810. PMC: 3141878. DOI: 10.1124/pr.110.004135. View

5.
Altawili A, Altawili M, Alzarar A, Abdulrahim N, Alquraish H, Alahmari M . Adverse Events of the Long-Term Use of Opioids for Chronic Non-cancer Pain: A Narrative Review. Cureus. 2024; 16(1):e51475. PMC: 10830133. DOI: 10.7759/cureus.51475. View